Effect of erythropoietin versus control group on the short-term prognosis in newborns with hypoxic- ischemic- encephalopathy
Phase 2
Recruiting
- Conditions
- Hypoxic ischemic encephalopathy.Hypoxic ischemic encephalopathy [HIE]P91.6
- Registration Number
- IRCT20120215009014N334
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Newborn,
Hypoxic- ischemic- encephalopathy
Exclusion Criteria
Congenital anomalies,
Gestational age less than 36 weeks,
Unperforated anus,
Intracranial hemorrhage
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to start oral nutrition. Timepoint: From the beginning of the intervention until two weeks thereafter. Method of measurement: By taking a history.;Seizure attacks. Timepoint: From the beginning of the intervention until two weeks thereafter. Method of measurement: With clinical examination.;Time of onset of consciousness. Timepoint: From the beginning of the intervention until two weeks thereafter. Method of measurement: With clinical examination.;Occurrence of death. Timepoint: From the beginning of the intervention until two weeks thereafter. Method of measurement: With clinical examination.;Duration of hospitalization. Timepoint: From the beginning of the intervention to two weeks thereafter. Method of measurement: Based on the medical document.
- Secondary Outcome Measures
Name Time Method Drug complications such as induced topical hypothermia, bradycardia and subcutaneous necrosis. Timepoint: From the beginning of the intervention until two weeks later. Method of measurement: With clinical examination.;Drug complications such as thrombocytopenia. Timepoint: From the beginning of the intervention up to two weeks later. Method of measurement: By laboratory tests.